GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Gross-Profit-to-Asset %

PharmaRoth Labs (PharmaRoth Labs) Gross-Profit-to-Asset % : 520.33% (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. PharmaRoth Labs's annualized Gross Profit for the quarter that ended in Mar. 2011 was $0.32 Mil. PharmaRoth Labs's average Total Assets over the quarter that ended in Mar. 2011 was $0.06 Mil. Therefore, PharmaRoth Labs's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2011 was 520.33%.


PharmaRoth Labs Gross-Profit-to-Asset % Historical Data

The historical data trend for PharmaRoth Labs's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Gross-Profit-to-Asset % Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Gross-Profit-to-Asset %
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 520.33

Competitive Comparison of PharmaRoth Labs's Gross-Profit-to-Asset %

For the Biotechnology subindustry, PharmaRoth Labs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaRoth Labs's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's Gross-Profit-to-Asset % falls into.



PharmaRoth Labs Gross-Profit-to-Asset % Calculation

PharmaRoth Labs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2010 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jun. 2010 )/( (Total Assets (A: Jun. 2009 )+Total Assets (A: Jun. 2010 ))/ count )
=0/( (0+0)/ 1 )
=0/0
=N/A %

PharmaRoth Labs's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2011 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2011 )/( (Total Assets (Q: Dec. 2010 )+Total Assets (Q: Mar. 2011 ))/ count )
=0.32/( (0.028+0.095)/ 2 )
=0.32/0.0615
=520.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2011) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


PharmaRoth Labs Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines